Vink, P., Shiramoto, M., Ogawa, M., Eda, M., Douha, M., Heineman, T., & Lal, H. (2016). Safety and immunogenicity of a Herpes Zoster subunit vaccine in Japanese population aged ≥50 years when administered subcutaneously vs. intramuscularly. Hum Vaccin Immunother.

Vink, Peter, Masanari Shiramoto, Masayuki Ogawa, Masahiro Eda, Martine Douha, Thomas Heineman, and Himal Lal. "Safety and Immunogenicity of a Herpes Zoster Subunit Vaccine in Japanese Population Aged ≥50 years When Administered Subcutaneously Vs. Intramuscularly." Hum Vaccin Immunother 2016.

Vink, Peter, et al. "Safety and Immunogenicity of a Herpes Zoster Subunit Vaccine in Japanese Population Aged ≥50 years When Administered Subcutaneously Vs. Intramuscularly." Hum Vaccin Immunother 2016.